Detalles de la búsqueda
1.
Correction to: Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
Breast Cancer Res
; 22(1): 14, 2020 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32005287
2.
Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
Breast Cancer Res
; 21(1): 135, 2019 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31801615
3.
Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients.
Breast Cancer Res
; 22(1): 2, 2019 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892336
4.
Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.
Br J Cancer
; 120(2): 247-255, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30563991
5.
Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.
Breast Cancer Res
; 20(1): 44, 2018 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29880014
6.
Abiraterone shows alternate activity in models of endocrine resistant and sensitive disease.
Br J Cancer
; 119(3): 313-322, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29991699
7.
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Breast Cancer Res
; 18(1): 58, 2016 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27246191
8.
Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer.
Breast Cancer Res
; 17: 35, 2015 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25888249
9.
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers.
Breast Cancer Res
; 16(5): 447, 2014 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-25358600
10.
ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.
PLoS Genet
; 7(4): e1001382, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21552322
11.
Involving multiple stakeholders in assessing and reviewing a novel data visualisation tool for a national neonatal data asset.
BMJ Health Care Inform
; 30(1)2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720494
12.
Pilot feasibility study of a digital technology approach to the systematic electronic capture of parent-reported data on cognitive and language development in children aged 2 years.
BMJ Health Care Inform
; 30(1)2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37364923
13.
Members of the TEAD family of transcription factors regulate the expression of Myf5 in ventral somitic compartments.
Dev Biol
; 355(2): 372-80, 2011 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21527258
14.
Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo.
Breast Cancer Res
; 14(5): R132, 2012 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23075476
15.
More than words: Parent, Patient and Public Involvement perspectives on language used by clinical researchers in neonatal care.
Early Hum Dev
; 171: 105611, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35785689
16.
Elacestrant demonstrates strong anti-estrogenic activity in PDX models of estrogen-receptor positive endocrine-resistant and fulvestrant-resistant breast cancer.
NPJ Breast Cancer
; 8(1): 125, 2022 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36446866
17.
Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities.
Oncogene
; 39(25): 4781-4797, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32307447
18.
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.
Nat Commun
; 11(1): 4053, 2020 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32792481
19.
Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor-Positive Breast Cancer.
JNCI Cancer Spectr
; 2(2): pky005, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31360844
20.
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer.
Cancer Discov
; 8(9): 1176-1193, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29991605